| RS878853151 |
KDM5C
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS878853152 |
CUL4B
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS878853153 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS878853154 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS878853157 |
PDE8B
|
Health Risk |
Pathogenic |
Autosomal dominant striatal neurodegeneration type 1, Autosomal dominant striatal neurodegeneration type 1 |
| RS878853158 |
PDE8B
|
Health Risk |
Likely pathogenic |
Autosomal dominant striatal neurodegeneration type 1, Autosomal dominant striatal neurodegeneration type 1 |
| RS878853159 |
ACTN4
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis 1, Focal segmental glomerulosclerosis 1 |
| RS878853160 |
CDK13
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS878853161 |
SLC2A1
|
Health Risk |
Pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS878853162 |
TUBB
|
Health Risk |
Pathogenic/Likely pathogenic |
Complex cortical dysplasia with other brain malformations 6, Complex cortical dysplasia with other brain malformations 6 |
| RS878853163 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS878853164 |
KMT5B
|
Health Risk |
Likely pathogenic |
— |
| RS878853165 |
MAST1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations |
| RS878853167 |
WDFY3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS878853169 |
NBEA
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS878853170 |
DSC2
|
Health Risk |
Pathogenic |
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL |
| RS878853171 |
ITPR1
|
Health Risk |
Pathogenic |
Gillespie syndrome, Gillespie syndrome |
| RS878853172 |
ITPR1
|
Health Risk |
Pathogenic |
Gillespie syndrome, Gillespie syndrome |
| RS878853173 |
ITPR1
|
Health Risk |
Pathogenic |
Gillespie syndrome, Gillespie syndrome |
| RS878853174 |
ITPR1
|
Health Risk |
Pathogenic |
Gillespie syndrome, Gillespie syndrome |
| RS878853175 |
ITPR1
|
Health Risk |
Pathogenic |
Gillespie syndrome, Inborn genetic diseases |
| RS878853176 |
ITPR1
|
Health Risk |
Pathogenic |
Gillespie syndrome, Gillespie syndrome |
| RS878853177 |
ITPR1
|
Health Risk |
Pathogenic |
Gillespie syndrome, Gillespie syndrome |
| RS878853178 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS878853217 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS878853218 |
ACP5
|
Health Risk |
Pathogenic/Likely pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS878853221 |
CNTNAP1
|
Health Risk |
Pathogenic |
Neuropathy, congenital hypomyelinating |
| RS878853222 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS878853223 |
EYA4
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 10, Autosomal dominant nonsyndromic hearing loss 10 |
| RS878853224 |
TECTA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal dominant nonsyndromic hearing loss 12 |
| RS878853225 |
MYO6
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 22, Autosomal dominant nonsyndromic hearing loss 22 |
| RS878853226 |
COCH
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 9, Autosomal dominant nonsyndromic hearing loss 9 |
| RS878853227 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS878853228 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS878853229 |
TMC1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal dominant nonsyndromic hearing loss 36 |
| RS878853230 |
TMC1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal recessive nonsyndromic hearing loss 7 |
| RS878853231 |
LOXHD1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS878853232 |
TBC1D24
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 86, Autosomal recessive nonsyndromic hearing loss 86 |
| RS878853233 |
USH2A
|
Health Risk |
Pathogenic |
Nonsyndromic genetic hearing loss, Usher syndrome type 2A |
| RS878853234 |
MITF
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2A, Waardenburg syndrome type 2A |
| RS878853235 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Autosomal recessive nonsyndromic hearing loss 2 |
| RS878853236 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS878853238 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS878853239 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS878853242 |
POU3F4
|
Health Risk |
Pathogenic |
X-linked mixed hearing loss with perilymphatic gusher, X-linked mixed hearing loss with perilymphatic gusher |
| RS878853243 |
TSPAN12
|
Health Risk |
Pathogenic |
Atrophia bulborum hereditaria, Exudative vitreoretinopathy 5 |
| RS878853244 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS878853245 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS878853246 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS878853247 |
STK11
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS878853248 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS878853249 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS878853250 |
SCN8A
|
Health Risk |
Pathogenic |
6 conditions, Early-infantile DEE |
| RS878853251 |
HIVEP2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS878853252 |
RERE
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS878853253 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS878853255 |
NECTIN1
|
Health Risk |
Pathogenic |
Cleft lip/palate-ectodermal dysplasia syndrome, Cleft lip/palate-ectodermal dysplasia syndrome |
| RS878853256 |
TUBB3
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 1, Complex cortical dysplasia with other brain malformations 1 |
| RS878853257 |
TUBB3
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 1, Complex cortical dysplasia with other brain malformations 1 |
| RS878853258 |
TUBB3
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 1, Complex cortical dysplasia with other brain malformations 1 |
| RS878853259 |
TGM1
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS878853260 |
PARN
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS878853261 |
ORAI1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to ORAI1 deficiency, Combined immunodeficiency due to ORAI1 deficiency |
| RS878853262 |
LTBP3
|
Health Risk |
Pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS878853263 |
NAA10
|
Health Risk |
Pathogenic |
Ogden syndrome, Ogden syndrome |
| RS878853264 |
NAA10
|
Health Risk |
Pathogenic/Likely pathogenic |
Ogden syndrome, Intellectual disability |
| RS878853265 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS878853267 |
NANS
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Genevieve type |
| RS878853269 |
HIVEP2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS878853270 |
RERE
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS878853271 |
TELO2
|
Health Risk |
Conflicting classifications of pathogenicity |
TELO2-related intellectual disability-neurodevelopmental disorder, TELO2-related intellectual disability-neurodevelopmental disorder |
| RS878853274 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta with normal sclerae |
| RS878853275 |
ATP6AP1
|
Health Risk |
Pathogenic |
Immunodeficiency 47, Immunodeficiency 47 |
| RS878853276 |
ATP6AP1
|
Health Risk |
Pathogenic |
Immunodeficiency 47, Immunodeficiency 47 |
| RS878853277 |
ATP6AP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 47, Immunodeficiency 47 |
| RS878853278 |
ATP6AP1
|
Health Risk |
Pathogenic |
Immunodeficiency 47, Immunodeficiency 47 |
| RS878853279 |
TUBB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Complex cortical dysplasia with other brain malformations 1, Complex cortical dysplasia with other brain malformations 1 |
| RS878853280 |
FRRS1L
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS878853281 |
FRRS1L
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS878853282 |
FRRS1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS878853283 |
FRRS1L
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS878853284 |
TUBB2B
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 7, Complex cortical dysplasia with other brain malformations 7 |
| RS878853285 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853286 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853287 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS878853288 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853289 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853290 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853292 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853293 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853294 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS878853296 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853297 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS878853298 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853299 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853301 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853302 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853303 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853304 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS878853312 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |